argenx SE (ARGX)
919.21
-16.79
(-1.79%)
USD |
NASDAQ |
Oct 02, 16:00
919.20
-0.01
(0.00%)
After-Hours: 20:00
argenx Market Cap : 56.88B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 56.88B |
| October 01, 2026 | 57.92B |
| September 30, 2026 | 59.34B |
| September 29, 2026 | 60.07B |
| September 28, 2026 | 60.17B |
| September 25, 2026 | 59.38B |
| September 24, 2026 | 59.55B |
| September 23, 2026 | 58.53B |
| September 22, 2026 | 59.64B |
| September 21, 2026 | 61.15B |
| September 18, 2026 | 61.28B |
| September 17, 2026 | 61.62B |
| September 16, 2026 | 60.94B |
| September 15, 2026 | 60.63B |
| September 14, 2026 | 61.30B |
| September 11, 2026 | 60.92B |
| September 10, 2026 | 60.90B |
| September 09, 2026 | 62.03B |
| September 08, 2026 | 62.32B |
| September 04, 2026 | 63.93B |
| September 03, 2026 | 65.19B |
| September 02, 2026 | 65.31B |
| September 01, 2026 | 63.65B |
| August 31, 2026 | 63.84B |
| August 28, 2026 | 63.32B |
| Date | Value |
|---|---|
| August 27, 2026 | 65.53B |
| August 26, 2026 | 64.80B |
| August 25, 2026 | 63.09B |
| August 24, 2026 | 62.57B |
| August 21, 2026 | 64.35B |
| August 20, 2026 | 64.24B |
| August 19, 2026 | 63.92B |
| August 18, 2026 | 61.45B |
| August 17, 2026 | 61.13B |
| August 14, 2026 | 52.68B |
| August 13, 2026 | 53.03B |
| August 12, 2026 | 54.21B |
| August 11, 2026 | 53.51B |
| August 10, 2026 | 53.60B |
| August 07, 2026 | 53.53B |
| August 06, 2026 | 54.17B |
| August 05, 2026 | 53.71B |
| August 04, 2026 | 52.26B |
| August 03, 2026 | 51.41B |
| July 31, 2026 | 52.84B |
| July 30, 2026 | 54.00B |
| July 29, 2026 | 54.62B |
| July 28, 2026 | 53.98B |
| July 27, 2026 | 55.00B |
| July 24, 2026 | 56.82B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Autolus Therapeutics Plc | 473.77M |
| Forte Biosciences, Inc. | 1.577B |
| Akari Therapeutics Plc | 15.26M |
| Cellectis SA | 144.00M |
| DBV Technologies SA | 624.38M |
Market Cap Related Metrics
| PE Ratio | 35.03 |
| PS Ratio | 11.50 |
| Price to Free Cash Flow | 55.10 |
| Price | 919.21 |
| Earnings Yield | 2.85% |
| Operating PE Ratio | 39.88 |
| Normalized PE Ratio | 35.03 |